Loading data
MLABNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 249.13 m USD | 240.98 m USD | 216.19 m USD | 219.08 m USD | 184.34 m USD |
| Cost of revenue | 90.86 m USD | 90.11 m USD | 82.94 m USD | 85.39 m USD | 75.25 m USD |
| Gross profit | 158.27 m USD | 150.87 m USD | 133.25 m USD | 133.69 m USD | 109.09 m USD |
| Research and development expense | 20.31 m USD | 19.52 m USD | 19.3 m USD | 20.49 m USD | 15.77 m USD |
| Operating profit | 18.51 m USD | 16.34 m USD | -272.08 m USD | 3.32 m USD | 4.7 m USD |
| Interest expense | — | — | 5.7 m USD | 4.77 m USD | 3.89 m USD |
| Profit before tax | 12.01 m USD | 5.96 m USD | -275.65 m USD | -389 k USD | 3.57 m USD |
| Income tax expense | 5.3 m USD | 7.94 m USD | -21.4 m USD | -1.32 m USD | 1.7 m USD |
| Net income (reported basis) | 6.71 m USD | -1.97 m USD | -254.25 m USD | 930 k USD | 1.87 m USD |
| Net income attributable to common shareholders | 6.71 m USD | -1.97 m USD | -254.25 m USD | 930 k USD | 1.87 m USD |
| Basic earnings per share | 1.22 USD/share | -0.36 USD/share | -47.2 USD/share | 0.17 USD/share | 0.36 USD/share |
| Diluted earnings per share | 1.21 USD/share | -0.36 USD/share | -47.2 USD/share | 0.17 USD/share | 0.35 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.